Yahoo · Oct 2, 2026
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
Gilead Sciences (GILD) closed the most recent trading day at $144.74, moving 1.87% from the previous trading session.
NYSE · GILD
Gilead Sciences, Inc.
Healthcare · Drug Manufacturers - General
$144.23
Up+$2.38 (+1.65%)
Updated Oct 7, 2026, 7:47 PM
SID Score
7.0/10
Composite research score
Smart Money
48/100
Neutral
- Market cap
- 152.89B
- P/E ratio
- 18.89
- Dividend yield
- 2.72%
- 52-week range
- $116.88 – $157.29
- Volume
- 3.72M
- Avg. volume
- 7.34M
Price performance · GILD
GILD price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
GILD closed at $144.23 after 21 trading sessions, down 1.64% for the selected period.
- Last close
- $144.23
- Period change
- -1.64%
- Period low
- $143.72
- Period high
- $152.67
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $145.11 | $146.14 | $142.5982 | $144.23 | 3.72M |
| Oct 5, 2026 | $143.21 | $145.16 | $142.79 | $144.63 | 6.14M |
| Oct 2, 2026 | $147.65 | $148.00 | $144.00 | $144.74 | 5.04M |
| Oct 1, 2026 | $149.44 | $149.44 | $147.185 | $147.50 | 4.44M |
| Sep 30, 2026 | $150.875 | $151.28 | $148.98 | $149.05 | 5.36M |
| Sep 29, 2026 | $150.18 | $152.625 | $148.785 | $151.28 | 5.32M |
| Sep 28, 2026 | $149.795 | $152.74 | $149.41 | $152.21 | 5.08M |
| Sep 25, 2026 | $150.05 | $151.00 | $148.02 | $150.93 | 5.28M |
| Sep 24, 2026 | $151.10 | $152.975 | $149.59 | $149.69 | 5.08M |
| Sep 23, 2026 | $153.60 | $154.1999 | $150.06 | $151.37 | 6.19M |
| Sep 22, 2026 | $150.645 | $153.2807 | $148.65 | $152.67 | 5.08M |
| Sep 21, 2026 | $150.11 | $152.095 | $148.22 | $150.56 | 5.57M |
| Sep 18, 2026 | $150.56 | $153.23 | $149.57 | $150.11 | 16.42M |
| Sep 17, 2026 | $148.775 | $151.04 | $146.8901 | $150.89 | 7.84M |
| Sep 16, 2026 | $146.58 | $149.30 | $146.12 | $147.68 | 5.19M |
| Sep 15, 2026 | $144.002 | $146.35 | $142.94 | $146.30 | 4.54M |
| Sep 14, 2026 | $144.26 | $146.75 | $143.71 | $146.41 | 4.92M |
| Sep 11, 2026 | $145.24 | $145.99 | $143.50 | $143.72 | 4.2M |
| Sep 10, 2026 | $145.07 | $145.9066 | $143.67 | $144.81 | 6.02M |
| Sep 9, 2026 | $145.46 | $147.68 | $145.00 | $145.65 | 4.58M |
| Sep 8, 2026 | $146.98 | $148.6491 | $145.45 | $146.64 | 6.08M |
Latest GILD news
The latest Smart Investors Daily articles mentioning GILD.
Stock researchCompany · Overview
Company
Market Activity
Research & News
GILD research
Overview
Company profile and research snapshot.
Company profile
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $130.64
- Implied upside
- —
- Analysts
- 16
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 10, 2026 | HSBC | Buy | — |
| Aug 5, 2026 | RBC Capital | Sector Perform | — |
| Aug 5, 2026 | Cantor Fitzgerald | Overweight | — |
| Aug 5, 2026 | Needham | Buy | — |
| Jul 29, 2026 | Barclays | Equal-Weight | — |
News briefing
No generated briefing is available yet.
ChartMill · Oct 2, 2026
Gilead Sciences (NASDAQ:GILD) Combines Top Technical Strength With a High-Quality Breakout Setup
Gilead Sciences (GILD) earns a 10/10 Technical Rating and 8/10 Setup Quality on ChartMill's breakout screen. See entry, stop, and risk levels.
Yahoo · Oct 1, 2026
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Yahoo · Sep 30, 2026
Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors
In the latest trading session, Gilead Sciences (GILD) closed at $149.45, marking a -1.21% move from the previous day.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
